In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients

American Journal of Psychiatry

Volumn 172, Issue 11, 2015, Pages 1148-1159

  Frankle, W Gordon ^a   Cho, Raymond Y ^a   Prasad, Konasale M ^a   Mason, N Scott ^a   Paris, Jennifer ^a   Himes, Michael L ^a   Walker, Christopher ^a   Lewis, David A ^a   Narendran, Rajesh ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL C 11; GABA TRANSPORTER 1; TIAGABINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CARBON; FLUMAZENIL; NEUROTRANSMITTER UPTAKE INHIBITOR; NIPECOTIC ACID DERIVATIVE; SLC6A1 PROTEIN, HUMAN;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GABAERGIC TRANSMISSION; GAMMA RHYTHM; HUMAN; IN VIVO STUDY; LEARNING; LIGAND BINDING; MALE; MEDIAL TEMPORAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOMATOLOGY; VISUAL LEARNING; VOLUME OF DISTRIBUTION; CASE CONTROL STUDY; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; SCINTISCANNING; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; YOUNG ADULT;

ADULT; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CEREBRAL CORTEX; FEMALE; FLUMAZENIL; GABA MODULATORS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA RHYTHM; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NEUROTRANSMITTER UPTAKE INHIBITORS; NIPECOTIC ACIDS; POSITRON-EMISSION TOMOGRAPHY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; YOUNG ADULT;

EID: 84946142208     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.14081031     Document Type: Article

References (62)

1. Lewis DA, Hashimoto T, Volk DW: Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005;6:312-324
2. Lewis DA: Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia. Curr Opin Neurobiol 2014;26:22-26
3. Bartos M, Vida I, Jonas P: Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 2007;8:45-56
4. Howard MW, Rizzuto DS, Caplan JB, et al: Gamma oscillations correlate with working memory load in humans. Cereb Cortex 2003;13:1369-1374
5. Miltner WHR, Braun C, Arnold M, et al: Coherence of gamma-band EEG activity as a basis for associative learning. Nature 1999;397:434-436
6. Singer W, Gray CM: Visual feature integration and the temporal correlation hypothesis. Annu Rev Neurosci 1995;18:555-586
7. Tallon-Baudry C, Kreiter A, Bertrand O: Sustained and transient oscillatory responses in the gamma and beta bands in a visual shortterm memory task in humans. Vis Neurosci 1999;16:449-459
8. Andreasen NC, Rezai K, Alliger R, et al: Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992;49:943-958
9. Carter CS, Perlstein W, Ganguli R, et al: Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998;155:1285-1287
10. Weinberger DR, Berman KF, Illowsky BP: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, III: a new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 1988;45:609-615
11. Weinberger DR, Berman KF, Zec RF: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence. Arch Gen Psychiatry 1986;43:114-124
12. Weinberger DR, Berman KF: Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci 1996;351:1495-1503
13. Callicott JH, Bertolino A, Mattay VS, et al: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000;10:1078-1092
14. Manoach DS, Gollub RL, Benson ES, et al: Schizophrenic subjects showaberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000;48:99-109
15. Manoach DS, Press DZ, Thangaraj V, et al: Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 1999;45:1128-1137
16. Butler PD, Schechter I, Zemon V, et al: Dysfunction of early-stage visual processing in schizophrenia. Am J Psychiatry 2001;158:1126-1133
17. Carter CS, MacDonald AW 3rd, Ross LL, et al: Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry 2001;158:1423-1428
18. Rogowska J, Gruber SA, Yurgelun-Todd DA: Functional magnetic resonance imaging in schizophrenia: cortical response to motor stimulation. Psychiatry Res 2004;130:227-243
19. Sullivan EV, Shear PK, Lim KO, et al: Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia. Biol Psychiatry 1996;39:234-240
20. Frankle WG, Cho RY, Narendran R, et al: Tiagabine increases [11C] flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology 2009;34:624-633
21. Frankle WG, Cho RY, Mason NS, et al: [11C]Flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels. PLoS ONE 2012;7:e32443
22. Miller LG, Greenblatt DJ, Barnhill JG, et al: "GABA shift" in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA. Eur J Pharmacol 1988;148:123-130
23. Tallman JF, Thomas JW, Gallager DW: GABAergic modulation of benzodiazepine binding site sensitivity. Nature 1978;274:383-385
24. 11C]Ro15-4513 PET study. Neuroimage 2014;99:158-165
25. Koe BK, Kondratas E, Russo LL: [3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs. Eur J Pharmacol 1987;142:373-384
26. Busatto GF, Pilowsky LS, Costa DC, et al: Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am J Psychiatry 1997;154:56-63
27. Schröder J, Bubeck B, Demisch S, et al: Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory study. Psychiatry Res 1997;68:125-131
28. Epperson CN, Haga K, Mason GF, et al: Cortical gammaaminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2002;59:851-858
29. Spitzer RL, Williams JBW, Gibbon M, et al: The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry 1992;49:624-629
30. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
31. Nuechterlein KH, Green MF, Kern RS, et al: The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 2008;165:203-213
32. Price JC, Mayberg HS, Dannals RF, et al: Measurement of benzodiazepine receptor number and affinity in humans using tracer kineticmodeling, positron emission tomography, and [11C]flumazenil. J Cereb Blood Flow Metab 1993;13:656-667
33. Koeppe RA, Holthoff VA, Frey KA, et al: Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991;11:735-744
34. Möhler H, Okada T: Benzodiazepine receptor: demonstration in the central nervous system. Science 1977;198:849-851
35. Braestrup C, Albrechtsen R, Squires RF: High densities of benzodiazepine receptors in human cortical areas. Nature 1977;269:702-704
36. Abi-Dargham A, Laruelle M, Seibyl J, et al: SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. J Nucl Med 1994;35:228-238
37. Salmi E, Aalto S, Hirvonen J, et al: Measurement of GABAAreceptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects. Neuroimage 2008;41:260-269
38. Delforge J, Spelle L, Bendriem B, et al: Parametric images of benzodiazepine receptor concentration using a partial-saturation injection. J Cereb Blood Flow Metab 1997;17:343-355
39. Lewis DA, Curley AA, Glausier JR, et al: Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 2012;35:57-67
40. Moghaddam B, Javitt D: From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012;37:4-15
41. Conti F, Melone M, De Biasi S, et al: Neuronal and glial localization of GAT-1, a high-affinity gamma-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex. J Comp Neurol 1998;396:51-63
42. Kegeles LS, Mao X, Stanford AD, et al: Elevated prefrontal cortex g-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2012;69:449-459
43. Ongür D, Prescot AP, McCarthy J, et al: Elevated gammaaminobutyric acid levels in chronic schizophrenia. Biol Psychiatry 2010;68:667-670
44. Rowland LM, Kontson K, West J, et al: In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull 2013;39:1096-1104
45. Yoon JH, Maddock RJ, Rokem A, et al: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 2010;30:3777-3781
46. Goto N, Yoshimura R, Moriya J, et al: Reduction of brain gammaaminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T proton MRS study. Schizophr Res 2009;112:192-193
47. Kelemen O, Kiss I, Benedek G, et al: Perceptual and cognitive effects of antipsychotics infirst-episode schizophrenia: the potential impact of GABA concentration in the visual cortex. Prog Neuropsychopharmacol Biol Psychiatry 2013;47:13-19
48. Chen CM, Stanford AD, Mao X, et al: GABAlevel, gamma oscillation, and working memory performance in schizophrenia. Neuroimage Clin 2014;4:531-539
49. Tayoshi S, Nakataki M, Sumitani S, et al: GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schizophr Res 2010;117:83-91
50. Benes FM, Vincent SL, Marie A, et al: Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 1996;75:1021-1031
51. Benes FM, Wickramasinghe R, Vincent SL, et al: Uncoupling of GABA (A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Res 1997;755:121-129
52. Squires RF, Lajtha A, Saederup E, et al: Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses? Neurochem Res 1993;18:219-223
53. Kiuchi Y, Kobayashi T, Takeuchi J, et al: Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics. Eur Arch Psychiatry Neurol Sci 1989;239:71-78
54. Verhoeff NP, Soares JC, D'Souza CD, et al: [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Res 1999;91:163-173
55. Abi-Dargham A, Laruelle M, Krystal J, et al: Noevidence of altered in vivo benzodiazepine receptor binding in schizophrenia. Neuropsychopharmacology 1999;20:650-661
56. Asai Y, Takano A, Ito H, et al: GABAA/benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for alpha5 subunit. Schizophr Res 2008;99:333-340
57. Laruelle M, Frankle WG, Narendran R, et al: Mechanism of action of antipsychotic drugs: from dopamine D (2) receptor antagonism to glutamate NMDA facilitation. Clin Ther 2005;27(suppl A):S16-S24
58. Bourdelais AJ, Deutch AY: The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. Cereb Cortex 1994;4:69-77
59. Van Vreeswijk C, Abbott LF, Ermentrout GB: When inhibition not excitation synchronizes neural firing. J Comput Neurosci 1994;1:313-321
60. Tallon-Baudry C, Bertrand O: Oscillatory gamma activity in humans and its role in object representation. Trends Cogn Sci 1999;3:151-162
61. Sohal VS, Zhang F, Yizhar O, et al: Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009;459:698-702
62. Gandal MJ, Edgar JC, Klook K, et al: Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology 2012;62:1504-1518